Cart
sales@molnova.com
Imaprelimab
CAS No. 2014343-04-3
Imaprelimab( —— )
Catalog No. M37101 CAS No. 2014343-04-3
Imaprelimab (PRX-003) is a humanized IgG1 κ monoclonal antibody targeting melanoma cell adhesion molecule (MCAM), with antitumor activity and applications in studying inflammation, tumors, and psoriasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 565 | Get Quote |
|
| 5MG | 907 | Get Quote |
|
| 10MG | 1454 | Get Quote |
|
| 25MG | 2088 | Get Quote |
|
| 50MG | 2732 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameImaprelimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionImaprelimab (PRX-003) is a humanized IgG1 κ monoclonal antibody targeting melanoma cell adhesion molecule (MCAM), with antitumor activity and applications in studying inflammation, tumors, and psoriasis.
-
DescriptionImaprelimab (PRX-003) is a humanized IgG1κ anti-melanoma cell adhesion molecule (MCAM) monoclonal antibody. Imaprelimab is an antineoplastic agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2014343-04-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pelletier JPR, Mukhtar F. Passive Monoclonal and Polyclonal Antibody Therapies. Immunologic Concepts in Transfusion Medicine. 2020:251–348.
molnova catalog
related products
-
AA41612
AA41612 is a novel antagonist of melanopsin-mediated phototransduction.
-
Methylsyringol
Methylsyringol is a natural product from Pinus yunnanensis.
-
Substance P (7-11)
Substance P (7-11) is a C-terminal fragment of Substance P, which can cause an increase in the intracellular calcium concentration as measured by the fluorescent dye Fura-2. In addition, the C-terminal fragment of SP, SP-(7-11), increased PGE2 and collagenase production at concentrations greater than 1 mM.
